(HS Wombwell 078943 2025) Antimicrobial Updates for Primary Care: A Pharmacotherapy Focus

Course overview

This engaging and practical session, "Antimicrobial Updates for Primary Care: A Pharmacotherapy Focus," led by Dr. Eric Wombwell, a board-certified infectious disease pharmacist and clinical professor, will provide practitioners with the latest evidence-based strategies for managing common infectious diseases in the primary care setting. The presentation will delve into critical updates regarding penicillin allergies, differentiating true allergies from intolerances to ensure appropriate beta-lactam use. Dr. Wombwell will also review current treatment guidelines for community-acquired pneumonia, considering comorbidities and antibiotic resistance, and provide a review of Clostridioides difficile infection, including the use of recently approved fecal microbiota products. A significant portion of the session will be dedicated to urinary tract infections, covering first-line treatment options, the increasing role of fosfomycin and nitrofurantoin in the face of evolving resistance trends, new antibiotic approvals, and emerging guidance from WikiGuidelines and anticipated IDSA recommendations. The session will also address skin infections, including appropriate antibiotic choices and MRSA coverage, and recap the 2023 diabetic foot infection recommendations. Through case-based discussions and practical application of current guidelines, participants will enhance their ability to optimize antimicrobial prescribing, minimize adverse effects, and contribute to antimicrobial stewardship efforts.